Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03934983 · ClinicalTrials.gov registry record
Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 30
- Enrollment target
NCT03934983 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 30 participants.
The verdict
NCT03934983 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This pilot study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QStat Cartridge in trauma patients.
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-03-28 |
| Est. Completion | 2020-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03934983
The ClinicalTrials.gov registry entry for NCT03934983 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT03934983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03934983 about?
NCT03934983 is a clinical study titled "Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma". This pilot study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QStat Cartridge in trauma patients.
What is the current status of trial NCT03934983?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-03-28. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03934983?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03934983?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.